Selected research
Market Structure
Global Equol Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Equol Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Equol Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Equol Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Equol Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Equol Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Equol Supplements include Advanced Medical Care Inc, AEON TOPVALU Co.,Ltd., BELTA Co., Ltd., DHC Corp., KURUKURU, Naris Cosmetics CO.,Ltd, Nutrined, ORIHIRO and seedcoms, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Equol Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Equol Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Equol Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Equol Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.
Equol Supplements Segment by Company
Advanced Medical Care Inc
AEON TOPVALU Co.,Ltd.
BELTA Co., Ltd.
DHC Corp.
KURUKURU
Naris Cosmetics CO.,Ltd
Nutrined
ORIHIRO
seedcoms
OTSUKA Phamaceutical Co.Ltd.
Kobayashi Pharmaceutical
Equol Supplements Segment by Type
Capsule
Tablet
Other
Equol Supplements Segment by Application
Online Sales
Offline Sales
Equol Supplements Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equol Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Equol Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equol Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Equol Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Equol Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Equol Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Equol Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Advanced Medical Care Inc
- AEON TOPVALU Co.,Ltd.
- BELTA Co., Ltd.
- DHC Corp.
- KURUKURU
- Naris Cosmetics CO.,Ltd
- Nutrined
- ORIHIRO
- seedcoms
- OTSUKA Phamaceutical Co.Ltd.
- Kobayashi Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Equol Supplements Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Equol Supplements Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Equol Supplements Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Equol Supplements Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Equol Supplements Market Dynamics
- 2.1 Equol Supplements Industry Trends
- 2.2 Equol Supplements Industry Drivers
- 2.3 Equol Supplements Industry Opportunities and Challenges
- 2.4 Equol Supplements Industry Restraints
3 Equol Supplements Market by Manufacturers
- 3.1 Global Equol Supplements Revenue by Manufacturers (2021-2026)
- 3.2 Global Equol Supplements Sales by Manufacturers (2021-2026)
- 3.3 Global Equol Supplements Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Equol Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Equol Supplements Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Equol Supplements Manufacturers, Product Type & Application
- 3.7 Global Equol Supplements Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Equol Supplements Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Equol Supplements Players Market Share by Revenue in 2025
- 3.8.3 2025 Equol Supplements Tier 1, Tier 2, and Tier 3
4 Equol Supplements Market by Type
- 4.1 Equol Supplements Type Introduction
- 4.1.1 Capsule
- 4.1.2 Tablet
- 4.1.3 Other
- 4.2 Global Equol Supplements Sales by Type
- 4.2.1 Global Equol Supplements Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Equol Supplements Sales by Type (2021-2032)
- 4.2.3 Global Equol Supplements Sales Market Share by Type (2021-2032)
- 4.3 Global Equol Supplements Revenue by Type
- 4.3.1 Global Equol Supplements Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Equol Supplements Revenue by Type (2021-2032)
- 4.3.3 Global Equol Supplements Revenue Market Share by Type (2021-2032)
5 Equol Supplements Market by Application
- 5.1 Equol Supplements Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Equol Supplements Sales by Application
- 5.2.1 Global Equol Supplements Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Equol Supplements Sales by Application (2021-2032)
- 5.2.3 Global Equol Supplements Sales Market Share by Application (2021-2032)
- 5.3 Global Equol Supplements Revenue by Application
- 5.3.1 Global Equol Supplements Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Equol Supplements Revenue by Application (2021-2032)
- 5.3.3 Global Equol Supplements Revenue Market Share by Application (2021-2032)
6 Global Equol Supplements Sales by Region
- 6.1 Global Equol Supplements Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Equol Supplements Sales by Region (2021-2032)
- 6.2.1 Global Equol Supplements Sales by Region (2021-2026)
- 6.2.2 Global Equol Supplements Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Equol Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Equol Supplements Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Equol Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Equol Supplements Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Equol Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Equol Supplements Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Equol Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Equol Supplements Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Equol Supplements Revenue by Region
- 7.1 Global Equol Supplements Revenue by Region
- 7.1.1 Global Equol Supplements Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Equol Supplements Revenue by Region (2021-2026)
- 7.1.3 Global Equol Supplements Revenue by Region (2027-2032)
- 7.1.4 Global Equol Supplements Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Equol Supplements Revenue (2021-2032)
- 7.2.2 North America Equol Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Equol Supplements Revenue (2021-2032)
- 7.3.2 Europe Equol Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Equol Supplements Revenue (2021-2032)
- 7.4.2 Asia-Pacific Equol Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Equol Supplements Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Equol Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Advanced Medical Care Inc
- 8.1.1 Advanced Medical Care Inc Company Information
- 8.1.2 Advanced Medical Care Inc Business Overview
- 8.1.3 Advanced Medical Care Inc Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Advanced Medical Care Inc Equol Supplements Product Portfolio
- 8.1.5 Advanced Medical Care Inc Recent Developments
- 8.2 AEON TOPVALU Co.,Ltd.
- 8.2.1 AEON TOPVALU Co.,Ltd. Company Information
- 8.2.2 AEON TOPVALU Co.,Ltd. Business Overview
- 8.2.3 AEON TOPVALU Co.,Ltd. Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 AEON TOPVALU Co.,Ltd. Equol Supplements Product Portfolio
- 8.2.5 AEON TOPVALU Co.,Ltd. Recent Developments
- 8.3 BELTA Co., Ltd.
- 8.3.1 BELTA Co., Ltd. Company Information
- 8.3.2 BELTA Co., Ltd. Business Overview
- 8.3.3 BELTA Co., Ltd. Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 BELTA Co., Ltd. Equol Supplements Product Portfolio
- 8.3.5 BELTA Co., Ltd. Recent Developments
- 8.4 DHC Corp.
- 8.4.1 DHC Corp. Company Information
- 8.4.2 DHC Corp. Business Overview
- 8.4.3 DHC Corp. Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 DHC Corp. Equol Supplements Product Portfolio
- 8.4.5 DHC Corp. Recent Developments
- 8.5 KURUKURU
- 8.5.1 KURUKURU Company Information
- 8.5.2 KURUKURU Business Overview
- 8.5.3 KURUKURU Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 KURUKURU Equol Supplements Product Portfolio
- 8.5.5 KURUKURU Recent Developments
- 8.6 Naris Cosmetics CO.,Ltd
- 8.6.1 Naris Cosmetics CO.,Ltd Company Information
- 8.6.2 Naris Cosmetics CO.,Ltd Business Overview
- 8.6.3 Naris Cosmetics CO.,Ltd Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Naris Cosmetics CO.,Ltd Equol Supplements Product Portfolio
- 8.6.5 Naris Cosmetics CO.,Ltd Recent Developments
- 8.7 Nutrined
- 8.7.1 Nutrined Company Information
- 8.7.2 Nutrined Business Overview
- 8.7.3 Nutrined Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nutrined Equol Supplements Product Portfolio
- 8.7.5 Nutrined Recent Developments
- 8.8 ORIHIRO
- 8.8.1 ORIHIRO Company Information
- 8.8.2 ORIHIRO Business Overview
- 8.8.3 ORIHIRO Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 ORIHIRO Equol Supplements Product Portfolio
- 8.8.5 ORIHIRO Recent Developments
- 8.9 seedcoms
- 8.9.1 seedcoms Company Information
- 8.9.2 seedcoms Business Overview
- 8.9.3 seedcoms Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 seedcoms Equol Supplements Product Portfolio
- 8.9.5 seedcoms Recent Developments
- 8.10 OTSUKA Phamaceutical Co.Ltd.
- 8.10.1 OTSUKA Phamaceutical Co.Ltd. Company Information
- 8.10.2 OTSUKA Phamaceutical Co.Ltd. Business Overview
- 8.10.3 OTSUKA Phamaceutical Co.Ltd. Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 OTSUKA Phamaceutical Co.Ltd. Equol Supplements Product Portfolio
- 8.10.5 OTSUKA Phamaceutical Co.Ltd. Recent Developments
- 8.11 Kobayashi Pharmaceutical
- 8.11.1 Kobayashi Pharmaceutical Company Information
- 8.11.2 Kobayashi Pharmaceutical Business Overview
- 8.11.3 Kobayashi Pharmaceutical Equol Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Kobayashi Pharmaceutical Equol Supplements Product Portfolio
- 8.11.5 Kobayashi Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Equol Supplements Value Chain Analysis
- 9.1.1 Equol Supplements Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Equol Supplements Production Mode & Process
- 9.2 Equol Supplements Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Equol Supplements Distributors
- 9.2.3 Equol Supplements Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst